ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

April 28, 1978

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

In Brief: Stoval to Receive ACCC Award; Groopman, Sigal, Named to Board of Scientific Advisors

March 12, 1999

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

NCAB Approves Grants For Action Plan On Breast Cancer

September 22, 1995